Physician profile
Rami Zein
NPI 1134531098
$15,980.01
in general payments reported to CMS, 2019-2025
38 companies · $6,458 in 2025
The $6,458 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $677 · 2021: $823 · 2022: $1,015 · 2023: $3,374 · 2024: $2,826 · 2025: $6,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,206 · Travel and Lodging: $4,433 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,206.33 |
| Travel and Lodging | $4,433.26 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,744.41 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic, INC. | $2,393.73 | 2022-2025 | Corevalve Evolut R, Micra, Symplicity G3 |
| Abbott Laboratories | $2,232.34 | 2019-2025 | Optis, Pressurewire, Esprit |
| Inari Medical, INC. | $981.93 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $893.40 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $625.00 | 2019-2025 | Lifevest |
| Abiomed | $537.25 | 2024-2025 | Impella |
| Boston Scientific Corporation | $508.88 | 2021-2025 | Watchman Flx, General - Thrombectomy, Eluvia |
| Cardiovascular Systems INC. | $338.72 | 2020-2021 | |
| Stryker Corporation | $292.68 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Shockwave Medical, INC | $285.11 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.38 | 2023-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $210.17 | 2024-2025 | Assure Wcd |
| Chiesi USA, INC. | $192.96 | 2023-2025 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $166.17 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $144.97 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $135.00 | 2019-2024 | Xarelto |
| Recor Medical INC | $110.20 | 2024 | Paradise Renal Denervation System |
| Cardinal Health 200 LLC | $102.96 | 2019-2021 | |
| Surmodics, INC. | $97.11 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Heartflow, INC. | $96.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $87.60 | 2019-2025 | |
| Getinge USA Sales, LLC | $79.10 | 2020-2024 | Icast, Flixene |
| Angiodynamics, INC. | $59.43 | 2020-2024 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Teleflex LLC | $53.51 | 2023-2025 | Guideliner, Turnpike |
| Cathworks, INC. | $51.98 | 2023-2024 | Ffrangio |
| Pfizer INC. | $51.87 | 2023-2024 | |
| Tactile Systems Technology INC | $42.81 | 2025 | Flexitouch Plus, Nimbl |
| Novo Nordisk INC | $38.88 | 2022-2025 | Wegovy |
| Cardiva Medical, INC. | $38.63 | 2023 | Cardiva Vascade 6/7f Vcs |
| Kiniksa Pharmaceuticals International, Plc | $31.15 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $29.96 | 2025 | Opsumit, Uptravi |
| Penumbra, INC. | $24.76 | 2025 | Penumbra System |
| Bard Peripheral Vascular, INC. | $23.19 | 2023 | Venclose Maven Catheter |
| Cordis US Corp. | $17.36 | 2024 | Mynxgrip |
| Baxter Healthcare | $15.50 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bsn Medical INC | $15.24 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Zein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.